BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21543800)

  • 1. Proteostasis: a new therapeutic paradigm for pulmonary disease.
    Bouchecareilh M; Balch WE
    Proc Am Thorac Soc; 2011 May; 8(2):189-95. PubMed ID: 21543800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.
    Bouchecareilh M; Hutt DM; Szajner P; Flotte TR; Balch WE
    J Biol Chem; 2012 Nov; 287(45):38265-78. PubMed ID: 22995909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
    Bouchecareilh M; Conkright JJ; Balch WE
    Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis, an emerging therapeutic paradigm for managing inflammatory airway stress disease.
    Bouchecareilh M; Balch WE
    Curr Mol Med; 2012 Aug; 12(7):815-26. PubMed ID: 22697348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-1 antitrypsin deficiency: A model of alteration of protein homeostasis or proteostasis].
    Vignaud H; Cullin C; Bouchecareilh M
    Rev Mal Respir; 2015 Dec; 32(10):1059-71. PubMed ID: 26386628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin deficiency: biological answers to clinical questions.
    Coakley RJ; Taggart C; O'Neill S; McElvaney NG
    Am J Med Sci; 2001 Jan; 321(1):33-41. PubMed ID: 11202478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-1-antitrypsin deficiency].
    Bouchecareilh M
    Med Sci (Paris); 2014 Oct; 30(10):889-95. PubMed ID: 25311024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteostasis boundary in misfolding diseases of membrane traffic.
    Hutt DM; Powers ET; Balch WE
    FEBS Lett; 2009 Aug; 583(16):2639-46. PubMed ID: 19708088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study.
    Teckman JH
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):34-7. PubMed ID: 15187777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling general proteostasis: proteome balance in health and disease.
    Roth DM; Balch WE
    Curr Opin Cell Biol; 2011 Apr; 23(2):126-34. PubMed ID: 21131189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Biology Framework to Illuminate Proteostasis.
    Sebastian RM; Shoulders MD
    Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergent properties of proteostasis in managing cystic fibrosis.
    Balch WE; Roth DM; Hutt DM
    Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21421917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and chemical approaches to diseases of proteostasis deficiency.
    Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
    Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiency.
    Ordóñez A; Snapp EL; Tan L; Miranda E; Marciniak SJ; Lomas DA
    Hepatology; 2013 May; 57(5):2049-60. PubMed ID: 23197448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing genetic diversity captures the molecular basis of misfolding disease.
    Zhao P; Wang C; Sun S; Wang X; Balch WE
    Nat Commun; 2024 Apr; 15(1):3333. PubMed ID: 38637533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.